EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation

Pediatric Blood and Cancer

Volumn 49, Issue 6, 2007, Pages 869-872

  Kasow, Kimberly A ^a,b   Leung, Wing ^a,b   Horwitz, Edwin M ^a,b   Woodard, Paul ^a,b   Handgretinger, Rupert ^a,b   Hale, Gregory A ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; Epstein Barr virus; Haploidentical; Lymphoproliferative disorder; T cell depletion

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CD20 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOGLOBULIN; METRONIDAZOLE; OKT 3; RITUXIMAB; THIOTEPA; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASPERGILLUS FLAVUS; B LYMPHOCYTE; CASE REPORT; CYTOGENETICS; DEATH; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MINIMAL RESIDUAL DISEASE; MYCOSIS; PRIORITY JOURNAL; PROPHYLAXIS; T LYMPHOCYTE; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FEMALE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOPROLIFERATIVE DISORDERS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547743487     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20710     Document Type: Article

References (14)

1. Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988;72:520-529.
2. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988;71:1234-1243.
3. Thomas ED, Blume KG, Forman SJ, editors. Hematopoietic stem cell transplantation, 2nd edition. Massachusetts: Blackwell Sciences, Inc.; 1999. 612 p.
4. van Esser JW, Niesters HG, van der Holt B, et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002;99:4364-4369.
5. Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 1999;94:2208-2216.
6. Faye A, Vilmer E. Post-transplant lymphoproliferative disorder in children: Incidence, prognosis, and treatment options. Paediatr Drugs 2005;7:55-65.
7. Handgretinger R, Schumm M, Lang P, et al. Transplantation of megadoses of purified haploidentical stem cells. Ann NY Acad Sci 1999;872:351-361.
8. Davis CL, Harrison KL, McVicar JP, et al. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Clin Transplant 1995;9:53-59.
9. Papadopoulos EB, Ladanyi M, Emanuel D, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994;330:1185-1191.
10. Heslop HE, Savoldo B, Rooney CM. Cellular therapy of Epstein-Barr-virus- associated post-transplant lymphoproliferative disease. Best Pract Res Clin Haematol 2004;17:401-413.
11. Liu Z, Savoldo B, Huls H, et al. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas. Recent Results Cancer Res 2002;159:123-133.
12. Savoldo B, Rooney CM, Quiros-Tejeira RE, et al. Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. Am J Transplant 2005;5:566-572.
13. Kuehnle I, Huls MH, Liu Z, et al. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hematopoietic stem-cell transplantation. Blood 2000;95:1502-1505.
14. Gershburg E, Pagano JS. Epstein-Barr virus infections: Prospects for treatment. J Antimicrob Chemother 2005;56:277-281.